PRESS-RELEASE ·Filed Apr 7, 2026

CLOV

Clover Health Investments, Corp.
NEUTRAL
Impact 5/10
Horizonweeks Processed5mo ago WireGlobeNewswire
Press release: contract
Actionable Insight • Neutral

This is a strategic technology advancement rather than a near-term revenue driver. Traders should monitor for future commercial contracts with other health plans using Counterpart Health’s infrastructure, which could signal scalable B2B monetization.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CLOV ▲ +176.84% at T+60d
NEUTRAL call ✓ call won +176.84% · α vs SPY +163.57% · entry $1.90 → $5.26
Entry anchored
Apr 6, 04:54 PM ET
via exchange tick
T+1d
+1.05%
call +1.05% · α -1.49%
$1.92
settled 6mo ago
T+5d
+7.37%
call +7.37% · α +2.04%
$2.04
settled 6mo ago
T+20d
+39.47%
call +39.47% · α +29.69%
$2.65
settled 5mo ago
T+60d
+176.84%
call +176.84% · α +163.57%
$5.26
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Clover Health (CLOV) announced a new collaboration with HealthEx to enable its Medicare Advantage members to securely access and share clinical records and claims data through a streamlined, interoperable platform powered by Counterpart Health. The partnership enhances patient control over health data and extends Clover's interoperability infrastructure to support broader industry adoption.

Key Facts

  • Clover Health partnered with HealthEx to allow members to securely access and share clinical records and claims data.
  • The interoperability infrastructure is powered by Counterpart Health, Clover’s technology and services subsidiary.
  • Members can now consolidate health data without navigating multiple portals or logins.
  • The functionality is live and will be promoted to members for self-directed data sharing.
  • The collaboration supports federal interoperability goals and expands on prior integrations like Kno2.

Financial Impact

No immediate financial impact disclosed; likely incremental revenue potential for Counterpart Health from future health plan adoption.

revenuetechnology_adoptionstrategic_partnerships

Risk Factors

  • Limited near-term financial upside as the initiative is focused on member experience and infrastructure development.
  • Adoption by other health plans is uncertain and may take quarters to materialize.

Market Snapshot

Exchange
Nasdaq
Sector
Hospital & Medical Service Plans

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3269116
18 reports for CLOV
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+5▲ +2.36%Aug 17, 2026
Filters
Rows
Reports for CLOV — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 2/10
$4.56 $4.57▲ +0.22%▼ −2.34%$4.41 (−3.40%)
Aug 17, 2026
6w ago
Insider Cluster
BEARISH ★ 5/10
$4.23 $4.13▲ +2.36%▲ +2.16%$4.41 (−4.14%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 4/10
$4.39 $4.23▼ −3.64%▼ −3.24%$4.41 (+0.34%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.79 $4.27▼ −10.86%▼ −9.63%$4.41 (−8.04%)
Jul 17, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.68 $4.40▼ −5.98%▼ −5.85%$4.41 (−5.88%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$5.00 $4.82▼ −3.60%▼ −4.15%$4.41 (−11.90%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.80 $5.21▲ +8.54%▲ +9.58%$4.41 (−8.23%)
Showing 10 of 18

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 7, 2026